Astrazeneca (AZN) Receivables - Other (2009 - 2026)
Astrazeneca's Receivables - Other came in at $1.35 billion for Q2 2026, up 26.7% from $1.07 billion a year earlier and up 13.9% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Receivables - Other (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca's Receivables - Other was $1.33 billion, up 42.7% from FY2024.
- Receivables - Other carries a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- Going back by year, Receivables - Other was $930 million in FY2024 (+15.8%), $803 million in FY2023 (-3.8%), $835 million in FY2022 (-6.7%) and $895 million in FY2021 (+24.3%).
- The Q2 2026 figure represents the highest quarterly Receivables - Other since Q2 2014.
- Year-over-year, Receivables - Other has increased for ten consecutive quarters, with growth averaging 27.1% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q1 2022 (growth of 57.4%), and the weakest in Q1 2023 (a decline of 21.1%).
- Business Quant data shows AZN's Receivables - Other at $1.19 billion (Q1 2026), $1.33 billion (Q4 2025) and $1.16 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Bn |
| Mar 31, 2026 | 1.19 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 926.00 Mn |
| Dec 31, 2024 | 930.00 Mn |
| Sep 30, 2024 | 915.00 Mn |
| Jun 30, 2024 | 806.00 Mn |
| Mar 31, 2024 | 745.00 Mn |
| Dec 31, 2023 | 803.00 Mn |
| Sep 30, 2023 | 761.00 Mn |
| Jun 30, 2023 | 752.00 Mn |
| Mar 31, 2023 | 682.00 Mn |
| Dec 31, 2022 | 835.00 Mn |
| Sep 30, 2022 | 792.00 Mn |
| Jun 30, 2022 | 881.00 Mn |
| Mar 31, 2022 | 864.00 Mn |
| Dec 31, 2021 | 895.00 Mn |
| Sep 30, 2021 | 811.00 Mn |
API Access
Astrazeneca Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();